Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 5/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.61 |
| ▸ | EIF4H | Q15056 | 2/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CLK1 | P49759 | 1/20 | 0.53 |
| ▸ | CACNA1H | O95180 | 3/20 | 0.53 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30863494 | 0.87 | MEN1 (0.57) | SMN1; SMN2KMT2AMEN1HDAC6PABPC1 | |
| SCHEMBL27195715 | 0.87 | MEN1 (0.57) | SMN1; SMN2KMT2AMEN1HDAC6PABPC1 | |
| SCHEMBL27195737 | 0.87 | KMT2A (0.56) | SMN1; SMN2KMT2AMEN1HDAC6PABPC1 | |
| SCHEMBL27195712 | 0.83 | KMT2A (0.73) | SMN1; SMN2KMT2AMEN1HDAC6L3MBTL1 | |
| SCHEMBL30863469 | 0.83 | MAPT (0.58) | SMN1; SMN2KMT2AMEN1PABPC1EIF4H | |
| SCHEMBL27195689 | 0.82 | CACNA1H (0.51) | SMN1; SMN2KMT2AMEN1PABPC1EIF4H | |
| SCHEMBL27195692 | 0.82 | MAPT (0.49) | SMN1; SMN2KMT2AMEN1PABPC1EIF4H | |
| SCHEMBL27195700 | 0.81 | MEN1 (0.54) | SMN1; SMN2KMT2AMEN1PABPC1EIF4H | |
| SCHEMBL30863532 | 0.81 | MEN1 (0.54) | SMN1; SMN2KMT2AMEN1PABPC1EIF4H | |
| SCHEMBL27195708 | 0.81 | CACNA1H (0.51) | SMN1; SMN2KMT2AHDAC6POLBCACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-4353712-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2024-04-17 | — | — | EP | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024079072-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | BIODOL THERAPEUTICS (FR) | 2024-04-18 | — | — | WO | disclosed |
| EP-4353712-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2024-04-17 | — | — | EP | disclosed |